Abstract:Objective: Moyamoya disease (MMD) is an intracranial steno-occlusive pathology characterized by progressive narrowing of proximal large vessels, including the terminal internal carotid arteries (ICAs), middle cerebral arteries, or anterior cerebral arteries. Named for the "puff of smoke" appearance of the anomalous vascularization visualized on cerebral angiography, MMD lacks a well-defined etiology, although significant insights have been made, including the identification of a susceptibility gene, RNF213, in humans with the disease. A limitation to advancing the understanding and treatment of MMD has been the lack of experimental animal models that authentically reflect the clinical pathogenesis. In an effort to analyze characteristics of currently available models and identify strategies for future model generation, the authors performed a scoping review of experimental animal models that have been used to study MMD. Methods: A systematic search of PubMed, Web of Science, and Scopus was performed to identify articles describing animal models used to study MMD. Additional articles were identified via citation searching. Study selection and data extraction were performed by two independent reviewers based on defined inclusion and exclusion criteria. Results: A total of 44 articles were included for full-text review. The methods used to generate these animal models were broadly classified as surgical (n = 25, 56.8%), immunological (n = 7, 15.9%), genetic (n = 6, 13.6%), or a combination (n = 6, 13.6%). Surgical models typically involved permanent ligation of one or both of the common carotid arteries or ICAs to produce chronic cerebral hypoperfusion. Genetic models utilized known MMD or cerebrovascular disease-related genes, such as RNF213 or ACTA2, to induce heritable cerebral vasculopathy. Finally, immunological models attempted to induce vasculitis-type pathology by recapitulating the inflammatory milieu thought to underlie MMD. Conclusions: Models generated for MMD have involved three general approaches: surgical, immunological, and genetic. Although each reflects a key aspect of MMD pathogenesis, the failure of any individual model to recapitulate the development, progression, and consequences of the disease underscores the importance of future work in developing a multietiology model.

A review of animal models for burning mouth syndrome: Mechanistic insights and knowledge gaps

Burning mouth syndrome: current clinical, physiopathologic, and therapeutic data

Recent advances in the understanding of the aetiology and therapeutic strategies in burning mouth syndrome: Focus on the actions of cannabinoids

Current advances in research of burning mouth syndrome: biological nerve and social psychology patterns

A Systematic Review of Acupuncture or Acupoint Injection for Management of Burning Mouth Syndrome.

Local anesthesia nerve block for managing burning mouth syndrome: a scoping review

50: EFFECT OF LOW-LEVEL LASER THERAPY IN THE TREATMENT OF BURNING MOUTH SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS

Animal models in the study and treatment of orofacial pain

Saliva and tongue microbiota in burning mouth syndrome: An exploratory study of potential roles

Challenge in the diagnosis, evaluation, and management of burning mouth sensation: A retrospective cohort study

Proteomic profiling of whole-saliva reveals correlation between Burning Mouth Syndrome and the neurotrophin signaling pathway

Distinctive salivary oral microbiome in patients with burning mouth syndrome depending on pain intensity compared to healthy subjects

Experimental animal models for moyamoya disease and treatment: a pathogenesis-oriented scoping review

Zinc deficiency may be a cause of burning mouth syndrome as zinc replacement therapy has therapeutic effects

Salivary and serum biomarkers to evaluate psychological disorders in burning mouth syndrome: A systematic review and meta‐analysis

Animal models of chronic pain: Advances and challenges for clinical translation

World Workshop in Oral Medicine VII: Reporting of IMMPACT-recommended outcome domains in randomized controlled trials of burning mouth syndrome: A systematic review

Advancing Pain Understanding and Drug Discovery: Insights from Preclinical Models and Recent Research Findings

The improvement of pain symptoms in patients with burning mouth syndrome through combined laser and medication therapy

Assessing Orofacial Pain Behaviors in Animal Models: A Review

Human surrogate models of central sensitization: A critical review and practical guide